INFLUENCE OF GRANULATION AND COMPRESSION PROCESS VARIABLES ON FLOW-RATE OF GRANULES AND ON TABLET PROPERTIES, WITH SPECIAL REFERENCE TO WEIGHT VARIATION

被引:26
作者
MERKKU, P [1 ]
LINDQVIST, AS [1 ]
LEIVISKA, K [1 ]
YLIRUUSI, J [1 ]
机构
[1] UNIV OULU,DEPT PROC ENGN,CONTROL ENGN LAB,SF-90570 OULU,FINLAND
关键词
MULTILINEAR STEPWISE REGRESSION; 3(3) FACTORIAL DESIGN; FLUIDIZED BED GRANULATION; INLET AIR TEMPERATURE; ATOMIZING AIR PRESSURE; BINDER AMOUNT; GRANULE FLOW RATE; TABLET PROPERTIES;
D O I
10.1016/0378-5173(94)90046-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of three independent fluidized bed granulation process variables (inlet air temperature, atomizing air pressure and binder solution amount) on the flow rate of granules and on the tablet properties was studied using the 3(3) factorial design. The dependence of the flow rate of granules, the tablet friability and the disintegration time of tablets on the fluidized bed granulation process variables was explained using the multilinear stepwise regression analysis. The now time of the granules was affected by all three factors. The friability and the disintegration time of tablets were affected by the binder solution amount and the atomizing air pressure. The influence of inlet air temperature on the tablet responses was insignificant.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 18 条
[1]  
AULTON M, 1978, MANUF CHEMIST AER N, V49, P50
[2]  
BOS CE, 1991, EUR J PHARM BIOPHARM, V37, P210
[3]  
BOS CE, 1991, EUR J PHARM BIOPHARM, V37, P204
[4]   BATCH PRODUCTION OF PHARMACEUTICAL GRANULATIONS IN A FLUIDIZED BED .1. EFFECTS OF PROCESS VARIABLES ON PHYSICAL PROPERTIES OF FINAL GRANULATION [J].
DAVIES, WL ;
GLOOR, WT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (12) :1869-&
[6]   TABLET PROPERTIES AS A FUNCTION OF THE PROPERTIES OF GRANULES MADE IN A FLUIDIZED-BED PROCESS [J].
DEJONG, JAH .
POWDER TECHNOLOGY, 1991, 65 (1-3) :293-303
[7]  
ELARINI SK, 1983, DRUGS MADE GER, V26, P205
[8]  
GAMLEN MJ, 1982, INT J PHARM TECH PRO, V3, P108
[9]  
GOMEZAMOZA JL, 1991, EUR J PHARM BIOPHARM, V37, P142
[10]  
MERKKU P, 1993, EUR J PHARM BIOPHARM, V39, P112